Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
11.02
0.00 (0.00%)
Jul 16, 2025, 4:00 PM - Market closed

Verve Therapeutics Revenue

Verve Therapeutics had revenue of $32.98M in the quarter ending March 31, 2025, with 479.03% growth. This brings the company's revenue in the last twelve months to $59.61M, up 271.44% year-over-year. In the year 2024, Verve Therapeutics had annual revenue of $32.33M with 174.98% growth.

Revenue (ttm)
$59.61M
Revenue Growth
+271.44%
P/S Ratio
15.92
Revenue / Employee
$217,566
Employees
274
Market Cap
984.32M

Revenue Chart

Created with Highcharts 11.4.8Verve Therapeutics Revenue - Annual1.94M1.94M11.76M11.76M32.33M32.33M20202021202220232024-10M20M30M

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202432.33M20.57M174.98%
Dec 31, 202311.76M9.82M505.77%
Dec 31, 20221.94M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.